Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial-Reference-Cited by-同舟云学术

Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial

Published:2008-05 Issue:9626 Volume:371 Page:1753-1760
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Weng Jianping,Li Yanbing,Xu Wen,Shi Lixin,Zhang Qiao,Zhu Dalong,Hu Yun,Zhou Zhiguang,Yan Xiang,Tian Haoming,Ran Xingwu,Luo Zuojie,Xian Jing,Yan Li,Li Fangping,Zeng Longyi,Chen Yanming,Yang Liyong,Yan Sunjie,Liu Juan,Li Ming,Fu Zuzhi,Cheng Hua

Publisher

Elsevier BV

Subject

General Medicine

Reference25 articles.

1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);Lancet,1998

2. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34);Lancet,1998

3. β-cell failure in diabetes and preservation by clinical treatment;Wajchenberg;Endocrine Rev,2007

4. Induction of long-term glycaemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment;Ilkova;Diabetes Care,1997

5. Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function;McFalane;Diabet Med,2001

Cited by 662 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between uncontrolled hyperglycemia (Type-2 Diabetes) and cardiovascular sequelae in patients with and without insulin;Saudi Pharmaceutical Journal;2024-10

2. Evaluating remission of type 2 diabetes using a metabolic intervention including fixed‐ratio insulin degludec and liraglutide: A randomized controlled trial;Diabetes, Obesity and Metabolism;2024-09-06

3. β-cell function and long-term glycemic control in patients newly diagnosed with type 2 diabetes with moderate hyperglycemia after a 6-month course of basal insulin therapy;Diabetes Research and Clinical Practice;2024-09

4. Patients with type 2 diabetes who achieve reduced postprandial glucose levels during insulin intensive therapy may have a better recovery of β-cell function;Diabetes Research and Clinical Practice;2024-09

5. Potential of Fasting C-peptide to Glucose Ratio and Triglyceride Glucose Index as Markers for β-Cell Dysfunction and Insulin Resistance in Patients With Type 2 Diabetes on Insulin Therapy;Cureus;2024-08-09